FDA Import Refusal AEK-8060561-8/11/1 — AbbVie Inc.
The FDA refused shipment AEK-8060561-8/11/1 from AbbVie Inc. (United States) on Nov 24, 2020. The refused product falls under Drugs and Biologics — LEUPROLIDE ACETATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 24, 2020
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62IDL86 LEUPROLIDE ACETATE (ANTI-NEOPLASTIC)
- Charges
- 75